Speaker illustration

Doctor Daniel Gras


Dr. Gras is a pioneer in the study of non-conventional pacing indications, including atrial arrhythmia prevention, pacing for hypertrophic obstructive cardiomyopathy and cardiac resynchronization therapy . He has been involved in the PIC Study and in the MUSTIC trial as an investigator, in the InSync, Compare, CARE-HF and Echo-CRT trials as an investigator and steering committee member. He is PI of the Freedom Study, of the Gentle Study and of the ongoing Biocontinue Trial. He is member of the DSMB for the ESTIM-rHTM study and of the CEC (Clinical Event Committee) for the NECTAR HF Trial.. He has a large experiences in CRT system implantation, with more than 2500 patients successfully operated, including live procedures. He is author or co-author of > 100 published articles; He is currently electrophysiologist at the Hôpital Privé du Confluent in Nantes, France, where > 1100 devices/year are implanted and > 1200 RF ablation cases/year (including > 600 AF) are performed

Diagnostics and treatment – bringing it all together in a clinical setting

Event: Heart Failure 2020

Topic: Diagnostic Methods

Session: How can you improve heart failure treatment?


CRT-D device replacement strategy according to previous ventricular tachycardia events: Preliminary Results of the BioCONTINUE Study

Event: ESC Congress 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac resynchronisation therapy


Device replacement strategy in CRT-D patients: interim results of the BioCONTINUE study

Event: EHRA 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac Resynchronization Therapy


CRT implantation - The easy and the difficult case

Event: EHRA 2018

Topic: Cardiac Resynchronization Therapy

Session: Cardiac Resynchronisation Therapy in 2018 (CRT)


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb